Global Interventional Neurology Device Market Size By Type (Cerebral Thrombectomy Devices, Carotid Artery Stenting (CAS) System), By Application (Hospital, Clinic), By Region, And Segment Forecasts, 2...

The Global Interventional Neurology Device Market was valued at USD 2.9 billion in 2023 and is expected to reach USD 6.4 billion by 2031, growing at a CAGR of 10.4% during the forecast period from 2023 to 2031. The growth of the market is driven by the rising incidence of neurovascular disorders such as ischemic and hemorrhagic strokes, technological advancements in minimally invasive devices, and increased awareness and diagnosis rates globally. With the global population aging and neurological diseases becoming more prevalent, the demand for interventional neurology procedures is witnessing a notable rise.

Drivers:

Rising Prevalence of Neurovascular Disorders:

Stroke is one of the leading causes of death and long-term disability worldwide. Increasing prevalence of conditions such as aneurysms, arteriovenous malformations, and carotid artery disease is driving demand for interventional procedures that use advanced devices like embolic coils, stents, and catheters.

Technological Advancements in Interventional Devices:

Innovations such as flow diverters, retrievable stents, and neurothrombectomy devices are improving the safety and efficacy of neurological interventions. The development of image-guided and AI-assisted tools is further enhancing clinical outcomes and surgeon precision.

Shift Toward Minimally Invasive Procedures:

Patients and healthcare systems are favoring minimally invasive surgeries due to shorter recovery times, lower risk of infection, and reduced hospitalization costs. This trend supports wider adoption of interventional neurology devices across hospitals and specialty clinics.

Restraints:

High Costs and Reimbursement Challenges:

The initial investment for interventional neurology procedures and equipment can be substantial. In many regions, limited reimbursement for these advanced procedures poses a barrier to market expansion, particularly in underfunded healthcare systems.

Limited Skilled Workforce:

Performing complex neurovascular interventions requires high-level expertise and training. A shortage of skilled neurosurgeons and interventional radiologists, especially in emerging markets, can limit adoption and patient access.

Opportunity:

Expansion in Emerging Economies:

Emerging markets in Asia-Pacific, Latin America, and the Middle East are investing in healthcare infrastructure and expanding access to neurology services. This provides significant growth potential for manufacturers to tap into underserved regions with rising patient populations.

Integration of AI and Robotics:

AI and robotic assistance in neurointerventional procedures can enhance precision and patient safety. This integration is expected to redefine procedural efficiency, especially in high-volume stroke centers and teaching hospitals.

Market by System Type Insights:

Based on system type, the Embolization Devices segment held the largest share of the market in 2023. These devices, including coils and liquid embolics, are widely used in the treatment of cerebral aneurysms and AVMs. The Neurothrombectomy Devices segment is projected to grow at the fastest rate, driven by the increasing incidence of ischemic stroke and the clinical preference for mechanical clot removal within critical time windows.

Market by End-Use Insights:

The Hospitals segment accounted for the largest share in 2023 due to the availability of advanced equipment and skilled neurosurgical teams. The Ambulatory Surgical Centers (ASCs) segment is expected to witness rapid growth owing to shorter procedure times, lower costs, and growing preference for outpatient care models in developed countries.

Market by Regional Insights:

North America dominated the global interventional neurology device market in 2023, supported by high stroke prevalence, early adoption of technology, and strong healthcare infrastructure. Asia-Pacific is expected to register the fastest CAGR during the forecast period due to rapid healthcare advancements, increasing stroke cases, and favorable government initiatives across China, India, and Southeast Asia.

Competitive Scenario:

Key players in the market include Medtronic plc, Stryker Corporation, Penumbra Inc., Johnson & Johnson (Cerenovus), Terumo Corporation, MicroVention Inc., and Balt Extrusion. These companies are investing in R&D, strategic acquisitions, and product launches to expand their neurointerventional portfolios.

Key Developments:

2023: Medtronic received FDA approval for its latest flow diverter device designed to treat wide-neck intracranial aneurysms.

2024: Penumbra Inc. launched a next-generation aspiration catheter for mechanical thrombectomy procedures.

2025: Stryker partnered with a digital health startup to integrate AI-driven diagnostic software into its stroke care platform.

Scope of Work – Global Interventional Neurology Device Market

Report Metric Details

Market Size (2023) USD 2.9 billion

Projected Market Size (2031) USD 6.4 billion

CAGR (2023–2031) 10.4%

Market Segments System Type (Embolization, Stents, Thrombectomy), End-use (Hospitals, ASCs), Region

Growth Drivers Rising neurovascular disease burden, technology advancements, preference for minimally invasive procedures

Opportunities Expansion in emerging markets, AI & robotic integration

FAQs:

1) What is the current market size of the Global Interventional Neurology Device Market?

The market was valued at USD 2.9 billion in 2023.

2) What is the major growth driver of the Global Interventional Neurology Device Market?

The primary growth driver is the rising prevalence of neurovascular disorders, especially stroke.

3) Which is the largest region during the forecast period in the Global Interventional Neurology Device Market?

North America remains the largest region due to its robust healthcare system and high adoption rate of advanced neurointerventional technologies.

4) Which segment accounted for the largest market share in the Global Interventional Neurology Device Market?

The Embolization Devices segment accounted for the largest market share in 2023.

5) Who are the key market players in the Global Interventional Neurology Device Market?

Key players include Medtronic, Stryker, Penumbra, Cerenovus (Johnson & Johnson), Terumo, MicroVention, and Balt.

Let me know if you want this in a downloadable Word format!